Mr. Doug Centilli is currently the President and CEO of Pathways NeuroPharma Inc., a company that works at the intersection of a novel combination of gene therapy and targeted drug delivery for the treatment of alcoholism and opioid addiction.
Mr. Centilli is an experienced executive with 2 decades of service at the United States Capitol in Washington DC, where he held the positions of Chief of Staff to United States Congressman Kevin Brady and Director of National Economic Policy for The Joint Economic Committee. He played key roles in healthcare policy including the areas of biotechnology and Research and Development. Doug is a Member of the Founders' Circle of The Texas A&M Institute for Genomic Medicine, a cutting-edge genomic research center that houses the world’s largest library of knockout embryonic mouse stem cells. Mr. Centilli’s public service began in the Texas Capitol in Austin where he held senior positions for members of the House of Representatives and also served as a Special Assistant in the Office of Governor Bill Clements. He serves on the board of the Archer Center at the University of Texas and Sights Unseen, a unique program that provides vision care in developing countries. Doug also serves on the advisory board of Helping a Hero, an organization that provides specially adapted homes and community support for severely injured military personnel. He is a graduate of Texas A&M University, where he was also a member of the Texas A&M football team.
Copyright © 2020 SUMMA Bio-Sciences - All Rights Reserved.